Rationale and design of a study to evaluate the effects of sitagliptin on atherosclerosis in patients with diabetes mellitus: PROLOGUE study

被引:11
|
作者
Oyama, Jun-ichi [1 ]
Ishizu, Tomoko [2 ]
Sato, Yasunori [3 ]
Kodama, Kazuhisa [1 ]
Bando, Yasuko K. [4 ]
Murohara, Toyoaki [4 ]
Node, Koichi [1 ]
机构
[1] Saga Univ, Dept Cardiovasc Med, Fac Med, Saga 8498501, Japan
[2] Univ Tsukuba, Fac Med, Div Clin Med, Tsukuba, Ibaraki, Japan
[3] Chiba Univ Hosp, Clin Res Ctr, Chiba, Japan
[4] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan
关键词
Atherosclerosis; Carotid artery intima-media thickness; Sitagliptin; CORONARY-ARTERY-DISEASE; INTIMA-MEDIA THICKNESS; ENDOTHELIAL FUNCTION; ULTRASOUND; STENOSIS; RISK;
D O I
10.1016/j.ijcard.2014.03.204
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:383 / 384
页数:3
相关论文
共 50 条
  • [1] Long-term effects of sitagliptin in patients with type 2 diabetes mellitus and hypertension: results from the PROLOGUE study
    Ye, Ziliang
    Li, Hui
    Lu, Haili
    Su, Qiang
    Li, Lang
    ONCOTARGET, 2017, 8 (67) : 111979 - 111997
  • [2] Effects of sitagliptin on coronary atherosclerosis evaluated using integrated backscatter intravascular ultrasound in patients with type 2 diabetes: rationale and design of the TRUST study
    Nozue, Tsuyoshi
    Fukui, Kazuki
    Koyama, Yutaka
    Fujii, Hiroyuki
    Kunishima, Tomoyuki
    Hikita, Hiroyuki
    Hibi, Kiyoshi
    Miyazawa, Akiyoshi
    Michishita, Ichiro
    HEART AND VESSELS, 2016, 31 (05) : 649 - 654
  • [3] Sitagliptin on carotid intima-media thickness in type 2 diabetes and hyperuricemia patients: a subgroup analysis of the PROLOGUE study
    Zhao, Yipin
    Wang, Huawei
    Ke, Dazhi
    Deng, Wei
    Ji, Yingying
    Yang, Jiaojiao
    Lin, Zebin
    Li, Guoxing
    Xiao, Li
    Tang, Jianmin
    Chen, Qingwei
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2021, 12
  • [4] Effects of sitagliptin on coronary atherosclerosis evaluated using integrated backscatter intravascular ultrasound in patients with type 2 diabetes: rationale and design of the TRUST study
    Tsuyoshi Nozue
    Kazuki Fukui
    Yutaka Koyama
    Hiroyuki Fujii
    Tomoyuki Kunishima
    Hiroyuki Hikita
    Kiyoshi Hibi
    Akiyoshi Miyazawa
    Ichiro Michishita
    Heart and Vessels, 2016, 31 : 649 - 654
  • [5] Rationale and design of a multicenter randomized controlled study to evaluate the preventive effect of ipragliflozin on carotid atherosclerosis: the PROTECT study
    Tanaka, Atsushi
    Murohara, Toyoaki
    Taguchi, Isao
    Eguchi, Kazuo
    Suzuki, Makoto
    Kitakaze, Masafumi
    Sato, Yasunori
    Ishizu, Tomoko
    Higashi, Yukihito
    Yamada, Hirotsugu
    Nanasato, Mamoru
    Shimabukuro, Michio
    Teragawa, Hiroki
    Ueda, Shinichiro
    Kodera, Satoshi
    Matsuhisa, Munehide
    Kadokami, Toshiaki
    Kario, Kazuomi
    Nishio, Yoshihiko
    Inoue, Teruo
    Maemura, Koji
    Oyama, Jun-ichi
    Ohishi, Mitsuru
    Sata, Masataka
    Tomiyama, Hirofumi
    Node, Koichi
    CARDIOVASCULAR DIABETOLOGY, 2016, 15
  • [6] Sitagliptin on Carotid Intima-Media Thickness in Type 2 Diabetes Mellitus Patients and Anemia: A Subgroup Analysis of the PROLOGUE Study
    Lu, Zhengri
    Ma, Genshan
    Chen, Lijuan
    MEDIATORS OF INFLAMMATION, 2020, 2020
  • [7] The Effect of Sitagliptin on Carotid Artery Atherosclerosis in Type 2 Diabetes: The PROLOGUE Randomized Controlled Trial
    Oyama, Jun-ichi
    Murohara, Toyoaki
    Kitakaze, Masafumi
    Ishizu, Tomoko
    Sato, Yasunori
    Kitagawa, Kazuo
    Kamiya, Haruo
    Ajioka, Masayoshi
    Ishihara, Masaharu
    Dai, Kazuoki
    Nanasato, Mamoru
    Sata, Masataka
    Maemura, Koji
    Tomiyama, Hirofumi
    Higashi, Yukihito
    Kaku, Kohei
    Yamada, Hirotsugu
    Matsuhisa, Munehide
    Yamashita, Kentaro
    Bando, Yasuko K.
    Kashihara, Naoki
    Ueda, Shinichiro
    Inoue, Teruo
    Tanaka, Atsushi
    Node, Koichi
    PLOS MEDICINE, 2016, 13 (06)
  • [8] Sitagliptin on carotid intima-media thickness in type 2 diabetes and hyperuricemia patients: A subgroup analysis of the PROLOGUE study
    Zhao, Yipin
    Lin, Zebin
    Chen, Qingwei
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2022, 128 : S7 - S7
  • [9] Rationale, design, and baseline characteristics of a clinical trial for prevention of atherosclerosis in patients with insulin-treated type 2 diabetes mellitus using DPP-4 inhibitor: the Sitagliptin Preventive study of Intima-media thickness Evaluation (SPIKE)
    Tomoya Mita
    Naoto Katakami
    Toshihiko Shiraiwa
    Hidenori Yoshii
    Tomio Onuma
    Nobuichi Kuribayashi
    Takeshi Osonoi
    Hideaki Kaneto
    Keisuke Kosugi
    Yutaka Umayahara
    Tsunehiko Yamamoto
    Kazunari Matsumoto
    Hiroki Yokoyama
    Mamiko Tsugawa
    Masahiko Gosho
    Iichiro Shimomura
    Hirotaka Watada
    Diabetology & Metabolic Syndrome, 6
  • [10] Rationale, design, and baseline characteristics of a clinical trial for prevention of atherosclerosis in patients with insulin-treated type 2 diabetes mellitus using DPP-4 inhibitor: the Sitagliptin Preventive study of Intima-media thickness Evaluation (SPIKE)
    Mita, Tomoya
    Katakami, Naoto
    Shiraiwa, Toshihiko
    Yoshii, Hidenori
    Onuma, Tomio
    Kuribayashi, Nobuichi
    Osonoi, Takeshi
    Kaneto, Hideaki
    Kosugi, Keisuke
    Umayahara, Yutaka
    Yamamoto, Tsunehiko
    Matsumoto, Kazunari
    Yokoyama, Hiroki
    Tsugawa, Mamiko
    Gosho, Masahiko
    Shimomura, Iichiro
    Watada, Hirotaka
    DIABETOLOGY & METABOLIC SYNDROME, 2014, 6